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1. Introduction 
Dinoseb (2-sec-butyl-4,6-dinitrophenol; CAS No. 88-85-7), a dark reddish-brown solid or 
dark orange viscous liquid, depending on the temperature (melting point: 32-42 °C) (Kidd & 
James, 1991), was approved for sale in the US in 1948 as a nitrophenolic herbicide in 
soybeans, vegetables, fruits, nuts, citrus and other field crops for the selective control of 
grass and broadleaf weeds (EXTOXNET, 1996; Schneider, 1986).  Dinoseb is also used as an 
insecticide for grapes and as a seed crop drying agent (EXTOXNET, 1996). Dinoseb is one of 
the chemicals available on the market on the basis of safety tests conducted by Industrial 
Bio-Test Laboratory, a concern later found to have submitted many flawed and even 
fraudulent reports on its procedures and results (Shabecoff, 1986). Subsequently, several 
studies showed that dinoseb has the potential to produce developmental toxicity including 
teratogenicity in rats, mice and rabbits (Giavini et al., 1986; Johnson, 1988; Preache & Gibson, 
1975a; Preache & Gibson, 1975b).  
Dinoseb as a pesticide was banned in the US in 1986 and the EU in 1991 owing to the 
potential risk of adverse health effects in humans (EXTOXNET, 1996; Rotterdam 
Convention, 2006), but dinoseb and its salts are still widely used as other agricultural 
products (PAN, 2006). Dinoseb as a pesticide is also banned in Japan, but its import is 
permitted (PAN, 2006). The volumes of dinoseb imported into Japan were estimated to be 
615 tons in fiscal year 2008 and 726 tons in fiscal year 2009 (NITE, 2009). Dinoseb is a high-
volume chemical with production or importation exceeding 1,000 tons per year in 
Organisation for Economic Co-operation and Development (OECD) member countries 
(OECD, 2004).  
Dinoseb is well absorbed from the gastrointestinal tract by the oral route and can pass 
through the placenta into the fetus in mice (Gibson & Rao, 1973).  A dermal study showed 
that in six hours young and adult female rats absorbed about 44% of the dose, while at 120 
hours 75.9% was absorbed in young and 92.5% in adults (Hall et al., 1992). Dinoseb shows 
relatively strong acute toxicity with an oral LD50 of 5-50 mg/kg in female rats (MHLW, 
2005), an intraperitoneal LD50 of 14.1-22.5 mg/kg in mice (US EPA, 2003b) and a dermal 
LD50 of 40 mg/kg in rabbits (US EPA, 2003b).  Inhalation LC50 is 33-290 mg/m3 for 4-hour 
exposure in rats (US EPA, 2003b). The basic mechanism of toxicity is thought to be 
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stimulation of oxidative metabolism in cell mitochondria by the uncoupling of oxidative 
phosphorylation (Leftwich et al., 1982).  Toxicity of dinoseb is enhanced by physical activity 
and high ambient temperature such as in an outdoor agricultural environment (Leftwich et 
al., 1982; US EPA, 2007).  Early symptoms of dinoseb exposure include hyperthermia, 
sweating, headache and confusion. Severe exposure may result in restlessness, seizures, 
coma and death (Leftwich et al., 1982; US EPA, 2006; US EPA, 2007).  
Exposure to dinoseb may occur by direct contact, ingestion or inhalation by users and 
producers, but indirect exposure to dinoseb via the environment is also anticipated.  The 
microbial breakdown of dinoseb has been demonstrated in soils, but dinoseb persists for 
about two to four weeks after application (Health Canada, 1991). A soil persistence of 24 to 
42 months was also observed in potato fields in Canada (O'Neill et al., 1989).  It has been 
reported that dinoseb was detected in water supplies in Canada and the US, and dinoseb 
residues were found in a cotton meal sample (Health Canada, 1991). 
Developmentally toxic effects of chemicals are influenced by the susceptibility of animal 
species and strains, the developmental stages of offspring and administration doses 
(Schardein, 2000; Wilson & Warkany, 1965). Teratogenicity is governed by dose-effect 
relations, but there are many variable factors such as the duration of chemical treatment 
(Wilson, 1966), frequency of dosing (Isaacson & Chaudhry, 1962), routes or modes of 
administration (Hansen & Billings, 1986; Kavlock et al., 1982; Kimmel, 1977; Staples et al., 
1976), the vehicle/suspending agent (Anderson & Morse, 1966) or a combination of 
chemicals (Wilson, 1964). Dinoseb is one of the chemicals that show differences in 
developmental toxicity according to these variable factors. We have already reviewed 
studies on the developmental effects of dinoseb exposed prenatally in experimental animals 
(Matsumoto et al., 2008c). In the following sections, available literature including new 
information concerning the developmental toxicity of dinoseb is introduced by focusing on 
the variable factors for risk assessment of dinoseb. It should be noted that the term dinoseb 
has been used in the literature to refer to several related chemicals based on 2-sec-butyl-4,6-
dinitrophenol (CAS: 88-85-7). In this chapter, dinoseb refers to the parent molecule only. 
2. Developmental toxicity in rabbits 
Table 1 shows the results of developmental toxicity of dinoseb in rabbits. There are gavage 
and dermal dose studies. The data are shown by routes of administration, in order of the 
most likely route of human intake. Only statistically significant effects are summarized 
unless noted otherwise. 
2.1 Gavage study in rabbits 
In a teratology study, 16 Chinchilla rabbits were exposed by gavage to dinoseb at 0 (vehicle: 
corn oil), 1, 3 or 10 mg/kg bw/day on gestation days (GDs) 6-18 (Research and Consulting 
Company, 1986). There were no differences in fetal body weight and sex ratio between the 
dinoseb-treated and control groups. In the highest dose group, there were neural tube 
defects including dyscrania associated with hydrocephaly, scoliosis, kyphosis, malformed or 
fused caudal or sacral vertebrae and/or encephalocele in a total of 40 fetuses in 11/16 litters. 
Eleven fetuses showed only hydrocephalus and/or micro- or anophthalmia, and 4 fetuses 
showed only skeletal abnormalities. No maternal death occurred. Body weight gain and 
food consumption in dams and number of implantations were not affected.   
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2.2 Dermal study in rabbits 
In a New Zealand white rabbit study, 16-17 pregnant rabbits were dermally given dinoseb 
at 0, 1, 3, 9 or 18 mg/kg bw/day on GDs 7-19 (Johnson, 1988). The dinoseb (no vehicle was 
used) was dermally applied to rabbits wearing Elizabethan collars for 6 hours, and the 
application site was wiped and then dried. Because overt maternal toxicity was observed at 
18 mg/kg bw/day and animals were also dying in the 9 mg/kg bw/day group, animals 
treated with dinoseb at the high dose were reassigned to the 9 mg/kg bw/day dose group 
and did not contribute to the evaluation. There were increased incidences of anophthalmia 
and hydrocephaly at 3 and 9 mg/kg bw/day. Dead and resorbed fetuses and fetuses with 
cleft palate, microphthalmia and microcephaly were increased at 9 mg/kg bw/day. At 3 
mg/kg bw/day and higher, hyperthermia and reduced body weight were observed in 
maternal rabbits.  
_________________________________________________________________________________ 
Species Dose Exposure time Developmental effect   
(Reference) 
_________________________________________________________________________________ 
Gavage 
Chinchilla rabbit  10 mg/kg GDs 6-18 External, internal and skeletal defects 
(Research and Consulting Company, 1986) 
 
Dermal 
NZ white rabbit 3 mg/kg GDs 7-19, Hydrocephaly, anophthalmia  
 9 mg/kg 6 h/day Dead and resorbed fetuses, cleft palate, 
   microcephaly, microphthalmia 
(Johnson, 1988) 
_________________________________________________________________________________  
Table 1. Developmental toxicity of dinoseb in rabbits 
GDs: gestation days  
3. Developmental toxicity of dinoseb in mice 
Tables 2.1-2.3 show the results of developmental toxicity studies of dinoseb in mice. There 
are gavage, intraperitoneal (i.p.) and subcutaneous (s.c.) administration studies. The data are 
shown by routes of administration, in order of the most likely route of human intake. Only 
statistically significant effects are summarized unless noted otherwise. 
3.1 Gavage studies in mice 
Pregnant CD-1 mice were administered dinoseb in corn oil on GDs 8-12 at 15 mg/kg 
bw/day, the expected maximum tolerated dose level of dinoseb. No effects were observed 
in reproductive and developmental parameters (Chernoff & Kavlock, 1982). Pregnant CD-1 
mice were given dinoseb in corn oil by gavage at 26 or 33 mg/kg bw on GD 7. Two out of 40 
pregnant animals died at 33 mg/kg bw, but percent mortality and body weight of pregnant 
mice were not changed. An increased incidence of supernumerary ribs was observed in both 
dinoseb-treated groups. The authors noted that increased incidence of supernumerary ribs 
may be a response to a non-specific disruption in maternal status (Kavlock et al., 1985).  
Administration of dinoseb to pregnant CD-1 mice by gavage on GDs 7-8 at 50 mg/kg 
bw/day in NaOH produced reduced fetal weight and increased incidence of fetuses with 
supernumerary ribs (71% in litters) without maternal death. The authors suggested that 
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supernumerary ribs are indicative of basic alterations in the development of the axial 
skeleton (Branch et al., 1996). A similar study conducted by Rogers et al. (2004) revealed a 
dose-related increased incidence of mouse fetuses with supernumerary ribs following 
maternal administration of dinoseb in NaOH at 50 mg/kg bw/day on GDs 7-8 and 
suggested that increased incidence of supernumerary ribs in fetuses is toxicologically 
significant. Skeletal anomalies such as sternum or vertebral centrum defects and fused ribs 
were also detected in fetuses of mice given dinoseb on GDs 7-8 at 50 mg/kg bw/day in 
NaOH. Although the treatment regimes of Branch et al. (1996) and Rogers et al. (2004) 
were essentially the same, they obtained different developmental effects in fetuses of mice 
given dinoseb at 50 mg/kg bw/day. Rogers et al. (2004) used 25 pregnant mice. On the 
other hand, Branch et al.  (1996) used only two pregnant mice, which is too few to evaluate 
the developmental toxicity. Therefore, it appears that a gavage dosing of dinoseb on GDs 7-8 
at 50 mg/kg bw/day can induce teratogenic effects without maternal toxicity in CD-1 mice.  
Dinoseb was administered to pregnant Swiss-Webster mice during GDs 7-15, GDs 9-11 or 
GDs 13-15 by gavage up to 50 mg/kg bw/day in NaOH. Gavage dosing of dinoseb 
produced no increased incidence of gross or soft-tissue anomalies. When dinoseb was given 
by gavage on GDs 9-11, six out of eight pregnant animals died at 50 mg/kg bw/day, but no 
effects were observed on developmental parameters. Skeletal variations such as 
supernumerary ribs and vertebrae were observed after doses of 20 and/or 32 mg/kg 
bw/day during GDs 7-15. The fetal crown-rump length (CRL) was also reduced at 32 
mg/kg bw/day after administration of dinoseb on GDs 7-15. A dose of 32 mg/kg bw/day 
dinoseb during GDs 13-15 induced absent or not ossified sternebrae. The dose levels that 
caused these adverse effects in fetuses were also lethal to some dams (Gibson, 1973). 
_________________________________________________________________________________ 
Species Dose Exposure time Developmental effect  
(Reference) _________________________________________________________________________________ 
CD-1 mouse 15 mg/kg GDs 8-12 No effects  
(Chernoff & Kavlock, 1982) 
 
CD-1 mouse 26, 33 mg/kg GD 7 Supernumerary ribs  
(Kavlock et al., 1985) 
 
CD-1 mouse 50 mg/kg GDs 7-8 Supernumerary ribs, ↓fetal weight  
(Branch et al., 1996) 
 
CD-1 mouse 50 mg/kg GDs 7-8 Supernumerary ribs, sternum and  
(Rogers et al., 2004)  vertebral centrum defects,   
   fused ribs 
 
SW mouse 50 mg/kg GDs 9-11 No effects (6/8 dams died)  
  
 20 mg/kg GDs 7-15 Supernumerary ribs and vertebrae  
 32 mg/kg  ↓fetal crown-rump length  
  
 32 mg/kg GDs 13-15  Absent or not ossified sternebrae 
(Gibson, 1973) 
____________________________________________________________________________  
Table 2.1. Developmental toxicity of dinoseb administered by gavage in mice 
GDs: gestation days 
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3.2 Intraperitoneal studies in mice 
No adverse effects were observed in reproductive and developmental parameters after an 
i.p. administration of dinoseb on GDs 7-15 at 5 mg/kg bw/day in Swiss-Webster mice; 
however, teratogenicity was obtained after i.p. administration of dinoseb on GDs 13-15 and 
GDs 9-11 (Gibson, 1973). An increased incidence of soft tissue malformation such as internal 
hydrocephalus was observed at 10-15.8 mg/kg bw/day in NaOH after i.p. treatment of 
dinoseb on GDs 9-11. At these doses, no maternal toxicity was observed. Increased 
incidences of defects in the limbs, tail, ribs, sternebrae and vertebrae, internal hydrocephaly 
and hydronephrosis were also induced at 17.7 mg/kg bw/day. Fetal body weight and 
number of fetuses were decreased at 18.8 mg/kg bw/day, and fetal CRL was decreased at 
20.0 mg/kg bw/day. At 17.7-20.0 mg/kg bw/day, dinoseb produced hyperthermia and 
death in dams. Dinoseb at 12.5 and 17.7 mg/kg bw/day on GDs 13-15 caused increased 
resorptions and decreased fetal body weight, but not maternal toxicity. Unlike 
administration of dinoseb on GDs 9-11, teratogenicity was not observed after administration 
of dinoseb on GDs 13-15 up to 17.7 mg/kg bw/day.  
In a later review study for perinatal nephropathies, Gibson (1976) stated that an incidence of 
30-40% of fetuses with hydronephrosis was observed at cesarean section owing to i.p. 
administration of dinoseb on GDs 9-11; however, no grossly observable hydronephrosis was 
evident in pups at 1 or 2 weeks of age. Renal alteration observed in offspring of mice given 
dinoseb seems to be a transient dilatation of the renal pelvis, which is also suggested by 
studies in rats (Daston et al., 1988; McCormack et al., 1980), as described in 4.3. On the other 
hand, i.p. treatment of dinoseb on GDs 9-11 at 15.8 mg/kg bw/day caused a impairment in 
p-aminophippuric acid (PAH) uptake into renal cortical slices of offspring at one and two 
weeks of age, and this effect was also evident at seven weeks of age (Gibson, 1976).  
Effects of food deprivation, phenobarbital (an inducer of chemical metabolism) and 2-
diethylaminoethyl-2,2-diphenylvalerate hydrochloride (SKF-525A; an inhibitor of chemical 
metabolism) on the developmental toxicity of dinoseb were evaluated in Swiss-Webster mice 
(Preache & Gibson, 1975a). Pregnant mice were treated i.p. with dinoseb at doses of 0-18.8 
mg/kg bw/day on GDs 9-11. These treatments were preceded by 24 or 48 h food deprivation 
or by pretreatment with phenobarbital or SKF-525A. Dinoseb-induced external and skeletal 
anomalies were increased by 24 h food deprivation. Effects of phenobarbital pretreatments on 
dinoseb-induced developmental toxicity were inconsistent at 17.7 and 18.8 mg/kg bw/day. At 
these doses, maternal death was not observed. Pretreatment with SKF-525A in combination 
with dinoseb at 15.8 mg/kg bw/day caused fetal anomalies, potentiated dinoseb-induced 
resorptions and produced maternal mortality. SKF-525A in combination with dinoseb at 17.7 
mg/kg bw/day was markedly lethal maternally; however, developmental parameters could 
not be analyzed because of the small number of litters surviving. Therefore, it is likely that the 
proximate toxicant for maternal toxicity was dinoseb itself. 
Swiss-Webster mice were treated with dinoseb on GDs 9-11 and maintained at an increased 
environmental temperature (32 °C) for 24 h or a decreased temperature (0-6 °C) for 1.5-4 h 
(Preache & Gibson, 1975b). Exposure to 32 °C enhanced adverse effects of dinoseb; it 
increased maternal mortality, decreased fetal body weight and increased the incidence of 
fetal anomalies at 7.5 mg/kg bw/day. Fetal body weight and the frequency of 
malformations were generally the same in groups exposed to low temperature and 
maintained at room temperature at 15.8-17.7 mg/kg bw/day. Maternal mortality was 
observed at doses that caused fetal toxicity. On the basis of these results, higher temperature 
enhanced the maternal and developmental toxicity of dinoseb. 
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_______________________________________________________________________________________ 
Species Dose Exposure time Developmental effect  
(Reference) 
___________________________________________________________________________________________________________________________________________ 
SW mouse 10 mg/kg GDs 9-11 Soft-tissue malformation  
 17.7 mg/kg   Gross and skeletal malformations 
 18.8 mg/kg  ↓Fetal body weight, no. of fetuses, 
    resorption  
 20 mg/kg  ↓Fetal crown-rump length 
  
 12.5-17.7 mg/kg GDs 13-15 ↓Fetal body weight, ↑resorption 
  
 5 mg/kg GDs 7-15 No effects 
(Gibson, 1973) 
 
SW mouse 15.8 mg/kg GDs 9-11 ↓PAH uptake by renal cortical slices 
(Gibson, 1976) 
 
SW mouse  15.8 mg/kg  GDs 9-11 Hydronephrosis, ectrodactyly, resorption 
  
 17.7, 18.8 mg/kg GDs 9-11  Hydronephrosis 
                                (combination with SKF-525A)   
 
 14.1 mg/kg GDs 9-11 Delayed ossification 
  15.8 mg/kg  External malformations 
 17.7 mg/kg  Hydronephrosis 
 18.8 mg/kg  ↓Fetal body weight, resorption  
 (combination with phenobarbital) 
 
 14.1 mg/kg GDs 9-11  Delayed ossification, ↓fetal body weight 
 15.8 mg/kg  Hydronephrosis, ectopic kidney,  
 (24 h deprivation)  internal hydrocephalus,  
   External and skeletal malformations 
 
 14.1 mg/kg GDs 9-11 ↓Fetal body weight, 
 15.8 mg/kg  External and skeletal malformations 
 (48 h deprivation) 
(Preache & Gibson, 1975a) 
 
SW mouse 7.5 mg/kg GDs 9-11 ↓Fetal body weight, external, soft-tissue 
 (32°C)  and skeletal malformations, 
   delayed ossification  
     
 15.8 mg/kg GDs 9-11 ↓Fetal body weight, external and 
                                (Room temp; wet)         soft-tissue malformations, resorption 
    
 15.8 mg/kg GDs 9-11  ↓Fetal body weight, external and 
               (6°C; wet)                         soft-tissue malformations 
     
 15.8 mg/kg GDs 9-11  ↓Fetal body weight  
 17.7 mg/kg  External and soft-tissue malformations,  
 (Room temp; dry)  skeletal retardation, variation  
   and malformation 
 
 17.7 mg/kg GDs 9-11  ↓Fetal body weight, external and soft-tissue 
                               (6°C; dry)  malformations, skeletal retardation, 
   variation and malformation 
(Preache & Gibson, 1975b) _______________________________________________________________________________________  
Table 2.2. Developmental toxicity of dinoseb administered by intraperitoneally in mice 
GDs: gestation days 
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3.3 Subcutaneous study of dinoseb 
Dinoseb was subcutaneously administered to pregnant Swiss-Webster mice during GDs 8-
16, 10-12 or 14-16 at 0, 10 or 17.7 mg/kg bw/day (Gibson, 1973). Adverse effects were 
observed only at 17.7 mg/kg bw/day. Dinoseb on GDs 14-16 induced increases in 
resorption rate and the incidence of cleft palate and decreases in the number of live fetuses, 
fetal CRL and fetal body weight. At this dose, one out of eight dams died. Dinoseb on GDs 
10-12 induced an increase in the incidence of fused ribs/vertebrae and absent or not ossified 
sternebrae, and on GDs 8-16 induced supernumerary ribs/vertebrae, absent or not ossified 
sternebrae, decreased fetal body weight and decreased fetal CRL without maternal toxicity. 
The authors concluded that an s.c. dose of dinoseb was not teratogenic and cleft palate 
induced by treatment of dinoseb was not considered as a toxicological response because this 
anomaly was not found in any i.p. treated groups, as described in 3.2, or in other s.c. 
treatment groups given 17.7 mg/kg bw/day. However, this anomaly can be considered as a 
toxic effect because the incidence of cleft palate was statistically significant, and other later 
studies showed that i.p. dose of dinoseb induced cleft palate in mice (Preache & Gibson, 
1975b) and in rabbits (Johnson, 1988). Moreover, a recent survey by international experts in 
the field of reproductive/developmental toxicology resulted in strong agreement that fused 
ribs and vertebrae can be considered as malformations (Solecki et al., 2001). Therefore, it can 
be concluded that an s.c. dosing of dinoseb in mice may have the potential to produce 
teratogenic effects in the same way as i.p. dosing of dinoseb. 
_________________________________________________________________________________ 
Species Dose Exposure time Developmental effect  
(Reference) 
_________________________________________________________________________________ 
SW mouse 17.7 mg/kg GDs 10-12  Fused ribs and vertebrae, absent or  
   not ossified sternebrae  
  
 17.7 mg/kg GDs 14-16 Cleft palate, ↑resorption, ↓no. of fetuses,  
   ↓fetal body weight,  
   ↓fetal crown-rump length 
  
 17.7 mg/kg GDs 8-16 Skeletal variations, ↓fetal body weight, 
   ↓fetal crown-rump length,  
(Gibson, 1973)   absent or not ossified sternebrae  
_________________________________________________________________________________  
Table 2.3. Developmental toxicity of dinoseb administered by subcutaneously in mice 
GDs: gestation days 
4. Developmental toxicity in rats 
Tables 3.1-3.3 show the results of developmental toxicity studies of dinoseb in rats. There are 
oral (gavage and diet) and i.p. administration studies. The data are shown by routes of 
administration, in order of the most likely route of human intake. Only statistically 
significant effects are summarized unless noted otherwise.  
4.1 Gavage studies in rats 
In our previous study, male Crj:CD(SD)IGS rats were administered dinoseb by gavage for a 
total of 42 days beginning 14 days before mating and females underwent this treatment for a 
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total of 44-48 days beginning 14 days before mating to day 6 of lactation at 0 (vehicle: corn 
oil) , 0.78, 2.33 or 7.0 mg/kg bw/day (Matsumoto et al., 2008a). As for the developmental 
parameters, no changes attributable to the chemical were noted in the 0.78 and 2.33 mg/kg 
bw/day dose groups. Eight of twelve females died and two animals were moribund during 
late pregnancy at 7.0 mg/kg bw/day. Developmental toxicity of dinoseb was not precisely 
estimated because only one dam with live pups was obtained at the highest dose, and 
newborn rats were only examined externally. No increased incidence of pups with an 
external malformation was noted in the dinoseb-treated groups.  
In teratology studies in rats, skeletal variation, delayed ossification and/or decreased fetal 
body weight was commonly observed in fetuses of dams treated with dinoseb. Giavini et al. 
(1986) administered dinoseb to pregnant CD rats by gavage in corn oil either once a day on 
GDs 5-14 at 0, 2.5, 5, 10 or 15 mg/kg bw/day or twice a day on GDs 5-12 at 15 (7.5 x 2) or 20 
(10 x 2) mg/kg bw/day. Dinoseb was also administered to pregnant rats on GDs 5-12 at 15 
mg/kg bw/day in NaOH. This vehicle was selected to conform to a vehicle used in a study by 
Gibson (1973) in which dinoseb in NaOH showed teratogenicity in mice when administered 
i.p. but not by gavage. An increased incidence of supernumerary ribs was observed at 10 
mg/kg bw/day and higher, and fetal weight was decreased at 15 and 20 mg/kg bw/day 
regardless of frequency of dosing or vehicle. Delayed ossification of caudal vertebrae, 
metacarpals or sternebrae was observed at a single dose of 15 mg/kg bw/day (in both corn oil 
and NaOH). These doses also caused maternal toxicities such as mortality and decrease in 
body weight gain. No malformations were observed in fetuses of dams treated with dinoseb 
under the test condition regardless of the dosing regimen or vehicle used in the experiment.  
Fetal body weight was decreased when pregnant Crl:CD rats were given dinoseb at 15 mg/kg 
bw/day with diet A (protein 21%, fat 3.5%, fiber 6.5%, ash 7.5% and N-free extractives 61.5%; 
Italiana Mangimi, Settimo Milanese, Italy) and diet B (protein 21%, fat 4.8%, fiber 4.2%, ash 
8.5% and N-free extractives 61.5%; Mangimi Piccioni, Gessate, Italy) on GDs 5-13 (Giavini et 
al., 1989). Dinoseb induced microphthalmia in fetuses of animals fed diet B but did not induce 
maternal toxicity. Maternal mortality and decreased maternal body weight gain were observed 
when dinoseb was given with diet A. Although developmental toxicity was different 
according to the type of diet, there were no differences in dinoseb concentrations in maternal 
plasma and in embryos between the two dietary groups.  
Wistar/Han rats were administered dinoseb by gavage on GDs 6-15 at 0, 1, 3 or 10 mg/kg 
bw/day (Health Canada, 1991). No information on the vehicle was presented in this study. 
Only slight depressions were observed in food consumption and body weight gain of dams 
at 10 mg/kg bw/day. Fetuses at the highest dose showed a slight decrease in body weight, 
and increases in the incidence of delayed ossification and incidence of skeletal variations, 
especially supernumerary ribs. At 3 mg/kg bw/day and higher, absence of thoracic 
vertebrae was observed. No further information is available for this study, but the result 
indicates that dosing of dinoseb by gavage is hazardous in Wistar/Han rats. 
The details of our new findings (Matsumoto et al., 2010) shown in Table 3.1 are described 
below (see 4.4). 
4.2 Feeding studies in rats 
Feeding of dinoseb to CD rats on GDs 5-14 produced a specific teratogenic effect, increased 
incidence of fetuses with microphthalmia, reduced fetal weight and increased incidence of 
fetuses with supernumerary ribs at 200 ppm (15 mg/kg bw/day) accompanied by 
decreased maternal body weight gain (Giavini et al., 1986). An increased incidence of fetuses 
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_________________________________________________________________________________
Species Dose Exposure time  Developmental effect  
(Reference) _________________________________________________________________________________ 
Crj:CD(SD)  7 mg/kg 44-48 days ↓ No. of dams delivered, 
IGS rat     ↓no. of dams with live pups at delivery 
(Matsumoto et al., 2008a)   
   
CD rat  10 mg/kg GDs 5-14  Skeletal variations 
 15 mg/kg   Delayed ossification, ↓fetal body weight 
  (in corn oil) 
  
 7.5, 10 mg/kg  GDs 5-12  Skeletal variations, ↓fetal body weight 
  (twice/day)    
  
 15 mg/kg  GDs 5-12  Skeletal variations, delayed ossification 
 (in NaOH)  ↓fetal body weight 
(Giavini et al., 1986)    
   
Crl:CD rat 15 mg/kg  GDs 5-13 ↓Fetal body weight, microphthalmia 
 (with diet B)     
  
 15 mg/kg GDs 5-13  ↓Fetal body weight 
  (with diet A)    
(Giavini et al., 1989) 
 
Wistar/Han 3 mg/kg  GDs 6-15  Absence of thoracic vertebrae, 
 rat a 10 mg/kg  Absence of thoracic vertebrae, 
   skeletal variations 
(Health Canada, 1991) 
    
SPF Crl:CD 8.0 mg/kg  GDs 6-15 ↓Fetal body weight, skeletal variations, 
(SD) rat b   delayed ossifications 
 10 mg/kg   ↓ Fetal body weight, skeletal variations, 
   delayed ossifications, microphthalmia 
(Matsumoto et al., 2010) _________________________________________________________________________________  
Table 3.1. Developmental toxicity of dinoseb administered by gavage in rats 
a: only secondary literature or abstract is available. 
b: the details are described in 4.4 
GDs: gestation days 
with microphthalmia and reduced fetal weight were also observed when pregnant Crl:CD 
rats were given dinoseb in diet B at 200 ppm on GDs 5-13. At this dose, maternal food 
consumption and body weight gain were decreased compared with those of control groups 
(Giavini et al., 1989). When dinoseb was fed with diet A, maternal food consumption and 
body weight gain were reduced, but no effects were found in fetuses (Giavini et al., 1989).  
These findings indicate that the developmental toxicity, including teratogenicity, of 
dinoseb in rats was influenced by diet composition (see 4.1 for the compositions of diet A 
and diet B). 
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Following feeding of dinoseb on GDs 5-14 at 0, 50, 100, 150, 200, 250, 300 and 350 ppm (0, 
3.26, 6.9, 9.23, 10.86, 9.38, 9.49 and 8.6 mg/kg bw/day) in SD rats, the number of resorptions 
at 200-350 ppm, early embryo loss at 200-350 ppm, and total intra-uterine loss at 150-350 
ppm were increased in a dose-related manner (Spencer & Sing, 1982; US EPA, 2003b). Body 
weight gain in dams was decreased at 150-350 ppm. At 200 ppm, hypoplastic tail was 
observed in 8 out of 62 fetuses and fetal weight was decreased. In decidualized females 
given dinoseb on days 7-10 of pseudopregnancy, uterine protein and glycogen 
concentrations were decreased at 200 ppm and higher in a dose-related manner. The authors 
suggested a toxic role of dinoseb in the uterine environment. 
Hall et al. (1978) provided a brief summary of a subchronic feeding study in which Sherman 
male and female rats were fed a diet containing dinoseb at 0, 50, 100, 150, 200, 300, 400 and 
500 ppm for 153 days. The 300, 400 and 500 ppm groups were terminated at day 21 of 
administration owing to mortality of 14, 100 and 100%, respectively, and only animals fed 
dinoseb up to 200 ppm were evaluated. Fertility, fecundity, neonate survival, weight gain, 
viability and lactation were depressed. No further details are available.  
In an unpublished five-generation study, decreased body weight gains were observed in 
parents during the pre-mating period (F0, F1 and F2) at 10 mg/kg bw/day dinoseb in the 
diet and in pups on postnatal day (PND) 21 (F1, F2 and F3) at 1, 3 and 10 mg/kg bw/day, 
but weights at birth were similar to the controls. Body weight gain in F4 and F5 pups was 
increased and absolute and relative gonadal weights in F4 pups were decreased at all dose 
levels. A low viability index was obtained (from F4 to F5) at all dose levels. No detailed 
information is available for this study (Health Canada, 1991; US EPA, 2003a).  
The details of our new findings (Matsumoto et al., 2010) shown in Table 3.2 are described 
below (see 4.4). 
4.3 Intraperitoneal studies in rats 
Two i.p. studies in rats showed similar results on developmental toxicity. When dinoseb 
was given to SD rats on GDs 9-11 at doses up to 15.8 mg/kg bw/day in NaOH, all pregnant 
rats given dinoseb at 11.2 mg/kg bw/day and higher and three of the 16 pregnant rats at 9.0 
mg/kg bw/day died. There were dilated renal pelvis and ureters in fetuses, decreased body 
weight in fetuses, and pathological changes in the liver and kidney in both fetal and 
neonatal rats at 8.0 mg/kg bw/day without maternal toxicity. At 9.0 mg/kg bw/day, fetal 
CRL was decreased, and neonatal body weight was decreased on PNDs 1 and 7 but not on 
PND 42. In surviving dams, dinoseb did not affect the number of live fetuses or the 
resorption rate in surviving dams (McCormack et al., 1980).  
When dinoseb was administered i.p. to pregnant SD rats on GDs 9-11 or 10-12 at 0-18.0 
mg/kg bw/day in NaOH, fetal body weight was decreased at 7.5 mg/kg bw/day and 
higher, but weights at birth and on PND 6 were not affected. Maternal death was observed 
at 8.0 mg/kg bw/day and higher, and 10.5 mg/kg bw/day was an approximate LD50 in 
pregnant rats. Postnatal observation on PND 30 revealed that there was a body weight 
reduction and an increase in relative kidney weight at 10.5 mg/kg bw/day. On PND 6, 
there were a deficit in urinary concentrating ability in pups of dams given dinoseb on GDs 
9-11 at 10.5 mg/kg bw/day (Daston et al., 1988). 
As described above, dinoseb produced suggestive renal damage in rat offspring following 
maternal administration. However, pathological changes in the kidney observed in prenatal 
rats were reduced in incidence or not detected at 42-day postpartum in the study of  
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_______________________________________________________________________________
Species Dose Exposure time Developmental effect  
(Reference) _________________________________________________________________________________ 
CD rat  200 ppm GDs 5-14 ↓Fetal body weight, microphthalmia, 
  (15 mg/kg)  skeletal variations  
(Giavini et al., 1986)    
     
Crl:CD rat 200 ppm  GDs 5-13 ↓Fetal body weight, microphthalmia 
 (diet B)    
  
 200 ppm  GDs 5-13  No effects 
  (diet A)    
(Giavini et al., 1989) 
 
SD rat 150 ppm  GDs 5-14 ↑Total intra-uterine loss 
  (9.23 mg/kg)    
 200 ppm   ↑Early embryonic loss, resorptions, 
 (10.86 mg/kg)  ↓fetal body weight, hypoplastic tail 
(Spencer & Sing, 1982; US EPA, 2003b)  
 
Sherman rat a  < 200 ppm 153 days ↓ Fertility, ↓fecundity, ↓neonate survival,  
   ↓body weight gain,  
   ↓viability, ↓ lactation 
(Hall et al., 1978)  
   
CD (SD) rat a 1, 3, 10 mg/kg 3-generation ↓Body weight gain in pups (F1, F2, F3) 
  
  Next ↓Body weight gain in pups (F4, F5),  
  2-generation ↓absolute/relative gonadal weight (F4), 
     viability index (F5) 
(Health Canada, 1991; US EPA, 2003a) 
     
SPF Crl:CD  120 ppm GDs 6-16 ↓Fetal body weight 
(SD) rat b (6.52 mg/kg)   
 10 mg/kg  ↓Fetal body weight, skeletal variations, 
 (8.0 mg/kg)  delayed ossifications 
(Matsumoto et al., 2010) 
_________________________________________________________________________________ 
↓
 
Table 3.2. Developmental toxicity of dinoseb administered in diet in rats  
a: only secondary literature or abstract is available 
b: the details are described in 4.4 
GDs: gestation days 
McCormack et al. (1980). In the study of Daston et al. (1988) a deficit in urinary 
concentrating ability observed during postnatal development also disappeared after 
functional maturation (PND 30). Prenatal incidence of dilated renal pelvis was not dose-
dependent. Moreover, Woo and Hoar (1972) noted that the renal parenchyma increased in 
weight rapidly, but that the renal papilla increased in length solely during late pregnancy, 
and they suggested that this discrepancy in growth rate frequently resulted in the kidney 
with an enlarged renal pelvis. Taken together, these renal effects appear to be a 
developmental delay, but not a permanent functional impairment. 
www.intechopen.com
 Herbicides and Environment 
 
554 
_________________________________________________________________________________
Species Dose Exposure time  Developmental effect  
(Reference) _________________________________________________________________________________ 
SD rat  8.0 mg/kg  GDs 9-11 ↓Fetal body weight, dilated renal pelvis  
   and ureters in fetuses  
   Pathological changes in liver and 
   kidney in fetuses and neonates  
 9.0 mg/kg  ↓Fetal crown-rump length, ↓ neonatal  
   body weight 
(McCormack et al., 1980) 
    
SD rat  7.5 mg/kg GDs 9-11, 10-12 ↓Fetal body weight 
 10.5 mg/kg  Functional defect of kidney (PND 6),  
   ↓body weight in pups (PND 30),  
   ↑relative weight of kidney (PND 30) 
(Daston et al., 1988) _________________________________________________________________________________  
Table 3.3. Developmental toxicity of dinoseb administered by intraperitoneally in rats  
GDs: gestation days 
PND: postnatal day 
4.4 Further clarification of teratogenicity in rats 
Several studies including our previous study did not demonstrate the teratogenicity of 
dinoseb in rats (Daston et al., 1988; Matsumoto et al., 2008a; McCormack et al., 1980), but we 
considered that the teratogenic potential of dinoseb in rats was unclear because of the 
influence of variable factors. Because detailed test conditions were not described in the 
studies of Giavini et al. (Giavini et al., 1989; Giavini et al., 1986), adequate experimental 
conditions for the production of fetal malformations by the administration of dinoseb to 
pregnant rats remained unknown. Therefore, we recently conducted gavage and feeding 
studies to clarify the experimental conditions that produce fetal malformations when 
dinoseb is given to pregnant rats (Matsumoto et al., 2010). 
Pregnant rats (12 animals/group) were given dinoseb by gavage at 0, 8.0 or 10 mg/kg 
bw/day on GDs 6-15 or in the diet (CRF-1; protein 22%, fat 5.7%, fiber 2.9%, ash 6.3% and 
N-free extractives 55.3%; Oriental Yeast Co., Ltd., Tokyo, Japan) at 0, 120 or 200 ppm on GDs 
6-16 (Figure 1). The feeding dose groups were expected to consume similar amounts of 
dinoseb to those in the gavage groups. Dinoseb induced dose-dependent decreases in 
maternal body weight gain and food consumption during pregnancy in all the dinoseb-
treated groups. The decrease in food consumption was greater in the feeding dose groups 
than the gavage dose groups; therefore, the decreased food consumption may be related to a 
reduced palatability of the diet in the feeding groups. Intakes of dinoseb by feeding dose 
were estimated to be 0, 6.52 and 8.50 mg/kg bw/day (0, 120 and 200 ppm). 
Significantly decreased body weights of fetuses were observed in all the dinoseb-treated 
groups, except for the group fed dinoseb at 120 ppm. Skeletal examinations of fetuses revealed 
an increased incidence of fetuses with skeletal variations in all the dinoseb-treated groups and 
delayed ossification at 8.0 and 10 mg/kg bw/day and at 200 ppm. An increased incidence of 
fetuses with microphthalmia was observed at 10 mg/kg bw/day, but there was no increased 
incidence of fetuses with external, internal or skeletal malformations in the groups given 
dinoseb at 8.0 mg/kg bw/day by gavage or 120 or 200 ppm by feeding (Table 3.1 and 3.2). 
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Fig. 1. A study design of prenatal developmental toxicity of gavage or feeding doses of 
dinoseb in rats (Matsumoto et al., 2010) 
Although the feeding dose of dinoseb at 200 ppm (15 mg/kg bw/day) was previously 
reported to be teratogenic in rats (Giavini et al., 1986), the feeding dose of dinoseb up to 200 
ppm (8.5 mg/kg bw/day) did not induce teratogenicity in our study. The diets used in the 
studies of Giaini et al. did not meet the current nutrient requirement of rats for fat (more 
than 5%) (ILAR, 1995; Suckow et al., 2005) while the diet used in our study is a standard rat 
diet; however, fat concentration seems unrelated to dinoseb-induced teratogenicity, and it 
seemed impossible to identify the definitive dietetic factor involved. Dose levels of dinoseb 
in our study might not have been sufficiently high to induce teratogenicity; however, 
pregnant rats did not consume sufficiently high amounts of dinoseb to produce fetal 
malformations because food consumption was reduced in the feeding groups. It seems 
unlikely that a feeding study is appropriate to evaluate the toxicity of dinoseb.  
Microphthalmia, which was found in rats after exposure to dinoseb by gavage or feeding 
(Giavini et al., 1989; Giavini et al., 1986) and in rabbits by gavage (Research & Consulting 
Company, 1986) or dermal application (Johnson, 1988), was predominantly observed after 
administration of dinoseb at 10 mg/kg bw/day by gavage. As a rule, the administration of a 
suitable dosage of a teratogen generally results in the production of some normal offspring, 
some malformed offspring and some dead or resorbed offspring (Schardein, 2000). In our 
study, the increased incidence of malformed fetuses was not accompanied by an increased 
incidence of intrauterine deaths of offspring after the administration of dinoseb. This 
phenomenon was also observed in the previous studies of Giavini et al. (Giavini et al., 1989; 
Giavini et al., 1986). One possible explanation for this is that microphthalmia itself is not 
lethal in utero. Because maternal death was observed after the gavage dose of dinoseb at 10 
mg/kg bw/day, the exposure range of dinoseb where malformations are observed seems to 
be narrow in rats. The findings of our study confirmed the experimental condition that 
could induce malformation in rats fed a standard diet. 
Feeding dose 
 
0, 120 or 200 ppm  
(0, 6.52 or 8.50 mg/kg) 
12 females/group  
Days 6-16 of pregnancy
Gavage dose 
 
0, 8.0 or 10 mg/kg/day 
12 females/group 
Days 6-15 of pregnancy
Dosing Without dosing
 
Day 15 Day 16  
Mating
Day 0 Pregnancy:  Day 20 Day 6
Necropsy 
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5. Discussion and conclusions 
A difficulty lies in the risk assessment of chemical compounds for developmental toxicity 
because there are many variable factors in the manifestation of developmental toxicity of 
chemicals. The administration route is one of the definitive factors for risk assessment of 
chemicals. The data obtained from animal experiments by oral administration are the most 
important for risk assessment of chemicals because the oral route is the most relevant route 
for human exposure to dinoseb.   
Gavage dosing of dinoseb during organogenesis in rabbits produced external, internal and 
skeletal malformations in fetuses without maternal toxicity at 10 mg/kg bw/day (Health 
Canada, 1991; US EPA, 2003a). In mice, gavage dosing of dinoseb during organogenesis 
induced skeletal variations and growth retardation at or above maternally toxic levels (26-50 
mg/kg bw/day) (Branch et al., 1996; Kavlock et al., 1985). Teratogenic effects were observed 
without maternal toxicity at 50 mg/kg bw/day by gavage in CD-1 mice (Rogers et al., 2004). 
Doses of dinoseb in rats during organogenesis induced skeletal variations and growth 
retardation at maternally toxic levels (8.0-20 mg/kg bw/day) by gavage and (6.52-15 mg/kg 
bw/day) by feeding (Giavini et al., 1986; Matsumoto et al., 2010). Malformations such as 
microphthalmia or hypoplastic tail were observed when dinoseb was given in the diet (10.86-15 
mg/kg bw/day) with maternal toxicity (Giavini et al., 1989; Giavini et al., 1986; Spencer & Sing, 
1982), but not in our study (Matsumoto et al., 2010). Microphthalmia was also observed when 
dinoseb was given by gavage (8.0-15 mg/kg bw/day) in CD rats with maternal toxicity (Giavini 
et al., 1989; Giavini et al., 1986; Matsumoto et al., 2010). In Wistar/Han rats, absence of thoracic 
vertebrae was observed by gavage dose of dinoseb at 3 mg/kg bw/day and higher without 
maternal toxicity. No detailed test condition is available for this study, but genetic difference in 
strains of rats may also influence the teratogenic potential of dinoseb. Although there are 
differences in susceptibility of developmental toxicity by the oral route among rabbits, mice and 
rats, namely susceptibility to developmental toxicity caused by dinoseb was greater in rabbits 
than in rats and mice, teratogenicity was noted at some doses without maternal toxicity in these 
animal species. More precisely, dinoseb can be a selective teratogen in these animal species.  
Dermal exposure is the next most likely route of exposure to dinoseb in humans, especially 
in users and producers. A dermal teratology study in rabbits showed a markedly increased 
incidence of dead and resorbed fetuses (Johnson, 1988). The survivors exhibited a high 
incidence of external and soft tissue malformations at application levels of dinoseb, but 
these dose levels were also maternally toxic.  
Prenatal i.p. and s.c. doses of dinoseb induced growth retardation, embryolethality and/or 
teratogenicity at or over the maternally toxic dose levels (10-20 mg/kg bw/day) in Swiss-
Webster mice (Gibson, 1973; Preache & Gibson, 1975a; Preache & Gibson, 1975b). Prenatal 
i.p. dose of dinoseb did not induce teratogenicity but induced growth retardation at or 
above the maternally toxic level in rats (Daston et al., 1988; McCormack et al., 1980). The 
teratogenic effects were observed with or without maternal toxicity in rats and mice, but the 
maternal toxicity of dinoseb seems greater in rats than in mice because dinoseb treatment 
(i.p.) during GDs 10-12 at 9.0 mg/kg bw/day caused 3/16 maternal deaths in rats 
(McCormack et al., 1980) while no maternal toxicity was observed at 15.8 mg/kg bw/day 
after i.p. dosing of dinoseb during GDs 10-12 in mice (Gibson, 1973). This may explain why 
teratogenicity was induced in mice, but not in rats, after i.p. dosing of dinoseb. It can be 
considered that maternal mice were tolerant to dose levels that can produce fetal 
malformations. Prenatal i.p. and s.c. doses of dinoseb also showed teratogenic potentials; 
however, these exposure routes are not likely to be relevant to human exposure to dinoseb 
and may not be important for risk assessment of dinoseb. 
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The developmental toxicity of dinoseb was also influenced by administration methods. These 
effects are considered to be related to differences in absorption due to the concentration of the 
chemical, duration of exposure and rate of release or to differences in metabolic fate and the 
nature of the metabolites reaching the embryo (Kalter, 1968). In fact, food deprivation for 24 h 
that enhanced external, soft-tissue and skeletal malformations slowed the disappearance of 
dinoseb from the plasma, but phenobarbital, which reduced developmental toxicity, hastened 
the disappearance of dinoseb from the plasma. SKF-525A pretreatment, which enhanced both 
maternal and developmental toxicity, decreased the rate of disappearance from the liver 
(Preache & Gibson, 1975a). When pregnant mice were administered dinoseb, either i.p. at 17.7 
mg/kg bw or by gavage at 32 mg/kg bw, the amount of dinoseb and its metabolites present in 
the embryo was greater after i.p. than oral administration, and peak levels were reached much 
earlier after i.p. administration (8 min vs. 12 h for oral) (Gibson & Rao, 1973). Developmental 
effects of i.p. dosing of dinoseb in mice can be related to rapid and relatively extensive uptake 
of the compound or its metabolites by the embryo.  
Over the years, many investigations have been conducted using laboratory animals to assess 
the risk to humans. We here reiterate the importance of the administration method to 
extrapolate laboratory results to humans.  We showed that fetal malformations by dinoseb 
were produced by the anticipated routes of human exposure (oral and dermal exposure) in 
laboratory animals. These results for routes/modes of administration relevant to human 
intake should be used for human risk assessment.  
There is no clear understanding of the fundamental mechanism of developmental toxicity of 
dinoseb, although an energy-deficient intrauterine environment due to uncoupling of 
cellular oxidative phosphorylation may explain dinoseb-induced developmental toxicity. A 
prenatal dose of thiabendazole, an ATP-synthesis inhibitor, induced a deformity involving 
reduced limb size in mice fetuses (Ogata et al., 1984), and ATP levels in fore- and hindlimb 
buds of fetuses were related to the incidence of this deformity (Tsuchiya & Tanaka, 1985). 
Dinoseb-induced teratogenicity may be related to the degree of reduction in ATP expression 
influenced by variable factors.  
Recent studies have investigated the role that mitochondria play in mediating apoptotic signals 
(Green & Kroemer, 2004; Linsinger et al., 1999; Little & Mirkes, 2002). Programmed cell death 
(PCD) is an essential component of normal physiological processes such as embryogenesis and 
normal tissue development (Vaux & Korsmeyer, 1999). Altering normal patterns of PCD could 
be teratogenic because areas of the body with a high incidence of malformations coincide with 
areas where PCD occurs (Knudsen, 1997; Sulik et al., 1988). Some studies showed a positive 
correlation between mitochondrial uncoupling activity and PCD (Maccarrone et al., 2001; 
Maccarrone et al., 2003), and 2,4-dinitrophenol, an uncoupling agent, enhanced the Fas 
apoptotic signal in Jurkat Bcl-2 cells (Linsinger et al., 1999).  These findings imply that the 
enhanced uncoupling of oxidative phosphorylation in mitochondria may alter normal patterns 
of PCD. However, the link between malformations and mitochondrial uncoupling activity is 
still poorly understood. In addition, we previously showed that these apoptotic activities could 
also involve in testicular toxicity of dinoseb in rats and mice (Matsumoto et al., 2008b). Further 
mechanistic studies are necessary to clarify the toxicity of dinoseb. 
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